GURUFOCUS.COM » STOCK LIST » Real Estate » REITs » Global Medical REIT Inc (NYSE:GMRE) » Definitions » Price-to-Free-Cash-Flow

Global Medical REIT (Global Medical REIT) Price-to-Free-Cash-Flow : 9.19 (As of Apr. 26, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Global Medical REIT Price-to-Free-Cash-Flow?

As of today (2024-04-26), Global Medical REIT's share price is $8.19. Global Medical REIT's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.89. Hence, Global Medical REIT's Price-to-Free-Cash-Flow Ratio for today is 9.19.

The historical rank and industry rank for Global Medical REIT's Price-to-Free-Cash-Flow or its related term are showing as below:

GMRE' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 9.08   Med: 12.03   Max: 53.09
Current: 9.21

During the past 13 years, Global Medical REIT's highest Price-to-Free-Cash-Flow Ratio was 53.09. The lowest was 9.08. And the median was 12.03.

GMRE's Price-to-Free-Cash-Flow is ranked better than
68.19% of 698 companies
in the REITs industry
Industry Median: 12.075 vs GMRE: 9.21

Global Medical REIT's Free Cash Flow per Share for the three months ended in Dec. 2023 was $0.22. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was $0.89.

During the past 13 years, Global Medical REIT's highest 3-Year average Free Cash Flow per Share Growth Rate was 61.60% per year. The lowest was -318.10% per year. And the median was 28.85% per year.


Global Medical REIT Price-to-Free-Cash-Flow Historical Data

The historical data trend for Global Medical REIT's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Global Medical REIT Price-to-Free-Cash-Flow Chart

Global Medical REIT Annual Data
Trend Aug14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - 12.46

Global Medical REIT Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 47.06 9.72 12.46

Competitive Comparison of Global Medical REIT's Price-to-Free-Cash-Flow

For the REIT - Healthcare Facilities subindustry, Global Medical REIT's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Global Medical REIT's Price-to-Free-Cash-Flow Distribution in the REITs Industry

For the REITs industry and Real Estate sector, Global Medical REIT's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Global Medical REIT's Price-to-Free-Cash-Flow falls into.



Global Medical REIT Price-to-Free-Cash-Flow Calculation

Global Medical REIT's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=8.19/0.891
=9.19

Global Medical REIT's Share Price of today is $8.19.
Global Medical REIT's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.89.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Global Medical REIT  (NYSE:GMRE) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Global Medical REIT Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Global Medical REIT's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Global Medical REIT (Global Medical REIT) Business Description

Traded in Other Exchanges
Address
7373 Wisconsin Avenue, Suite 800, Bethesda, MD, USA, 20814
Global Medical REIT Inc is a Maryland corporation engaged primarily in the acquisition of purpose-built healthcare facilities and the leasing of those facilities to strong healthcare systems and physician groups. Its healthcare facilities are located in secondary markets and suburbs of primary markets and are typically leased to single-tenants under triple-net leases. Its tenants are physician groups, regional or national healthcare systems or combinations thereof. The company's principal business objective is to provide attractive, risk-adjusted returns to its stockholders through a combination of reliable dividends and long-term capital appreciation.
Executives
Moore Roscoe M Jr director C/O HEMOBIOTECH, INC., 5001 SPRING VALLEY ROAD, SUITE 1040 WEST, DALLAS TX 75244
Henry Cole director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Jeffrey Busch director, officer: Chairman, President and CEO 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Lori Wittman director 191 NORTH WACKER DRIVE, SUITE 1200, CHICAGO IL 60606
Matthew Cypher director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Paula Crowley director 2 BETHESDA METRO CENTER, SUITE 440, BETHESDA MD 20814
Ronald Marston director 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Robert J Kiernan officer: Chief Financial Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Alfonzo Leon officer: Chief Investment Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Danica Holley officer: Chief Operating Officer 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Jamie Allen Barber officer: Secretary and General Counsel 7373 WISCONSIN AVENUE, SUITE 800, BETHESDA MD 20814
Allen Webb officer: SVP 4800 MONTGOMERY LANE SUITE 450, BETHESDA MD 20814
Huiqi Zhang director, 10 percent owner 40-44 WYNDHAM STREET, 24/F WYNDHAM PLACE, HONG KONG K3 00000
Notable Reward Ltd 10 percent owner VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110
Superior Glory Enterprises Ltd. 10 percent owner VISTRA CORPORATE SERVICES CENTRE, WICKHAMS CAY II, ROAD TOWN TORTOLA D8 VG1110